Home/Pipeline/Libtayo (cemiplimab)

Libtayo (cemiplimab)

Advanced Cutaneous Squamous Cell Carcinoma

MarketedActiveN/A

Key Facts

Indication
Advanced Cutaneous Squamous Cell Carcinoma
Phase
Marketed
Status
Active
Company

About Regeneron Pharmaceuticals

Regeneron is a premier biotechnology company with a mission to translate groundbreaking science into life-changing medicines for patients. Its achievements are anchored by its proprietary VelociSuite® technology platforms, which have enabled the development of a robust commercial portfolio and one of the industry's deepest pipelines. The company's strategy combines sustained internal R&D investment with selective, high-value collaborations, all supported by a fully integrated model from discovery to global commercialization.

View full company profile